|
Q1 FY2027
As of Jul 3, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 26, 2025
|
Q1 FY2026
As of Jun 27, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 27, 2024
|
Q1 FY2025
As of Jun 28, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 29, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Current assets: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Accounts receivable, net of allowance of $2,164 and $2,078, respectively | |||||||||||||||
| Related Party | |||||||||||||||
| Total accounts receivable, net of allowance of $2,164 and $2,078, respectively | |||||||||||||||
| Contract assets | |||||||||||||||
| Inventories | |||||||||||||||
| Section 45X credit receivable | |||||||||||||||
| Other current assets | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Total other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Other intangible assets, net | |||||||||||||||
| Deferred tax assets and other assets | |||||||||||||||
| Deferred tax assets | |||||||||||||||
| Other assets | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued expenses | |||||||||||||||
| Current portion of long-term debt | |||||||||||||||
| Deferred revenue | |||||||||||||||
| Other current liabilities | |||||||||||||||
| Related Party | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Total other current liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Long-term debt, net of current portion | |||||||||||||||
| Tax receivable agreement (TRA) liability | |||||||||||||||
| Long-term deferred revenue | |||||||||||||||
| Other liabilities | |||||||||||||||
| Liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Redeemable non-controlling interests | |||||||||||||||
| Stockholders’ equity: | |||||||||||||||
| Class A common stock, $0.0001 par value, 900,000,000 shares authorized, 151,654,811 shares and 149,391,483 shares issued and outstanding, respectively | |||||||||||||||
| Common Class A | |||||||||||||||
| Common Class B | |||||||||||||||
| Additional paid-in-capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| Non-controlling interest | |||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||
Loading...